Comparing a new software for eye refraction with traditional methods
Randomized Controlled Study on Subjective Refraction by Software Eye Test Technology Versus Retinoscopy
NA · Beijing Airdoc Technology Co., Ltd. · NCT06059521
This study is testing a new eye refraction software called Mobilerone to see if it gives accurate results for adults and older children with nearsightedness and astigmatism compared to traditional methods.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 120 (estimated) |
| Ages | 10 Years to 46 Years |
| Sex | All |
| Sponsor | Beijing Airdoc Technology Co., Ltd. (industry) |
| Locations | 3 sites (Beijing, Beijing Municipality and 2 other locations) |
| Trial ID | NCT06059521 on ClinicalTrials.gov |
What this trial studies
This study evaluates the accuracy and safety of a novel software refraction device called Mobilerone for adults and older children with myopia and astigmatism. Participants will undergo refraction testing using the Mobilerone software, which provides a subjective guide on screen, and the results will be compared to traditional retinoscopy methods. The aim is to determine if the software can provide reliable refractive measurements for those with ametropia. The study will include individuals with specific visual acuity and eye health criteria.
Who should consider this trial
Good fit: Ideal candidates are adults and older children with myopia and astigmatism who meet specific visual and health criteria.
Not a fit: Patients with hyperopia, presbyopia, or significant eye conditions such as keratoconus will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to a more accurate and user-friendly method for assessing refractive errors in patients with myopia and astigmatism.
How similar studies have performed: While the approach of using software for refraction is innovative, similar studies have shown promise in improving refractive assessment accuracy.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * • subject with ametropia on each eye ≤-12.00D * subject with best corrected visual acuity ≥ 20/25, no amblyopia * subject with normal transparency of eyes * subject with a healthy fundus that does not reveal major abnormalities that may affect vision due to the fluctuate situations * subject able to cooperate with the screen and the operator * subject without heavy drug treatment that may affect vision as synthetic antimalarials, corticosteroids * non-diabetic subject * non nystagmus subject * non-strabismus subject * subject who has not had eye surgery less than 1 year old Exclusion Criteria: * • subject with a topography showing an anomaly (keratoconus type or other) * subject with hyperopia or presbyopia * subject with mild myopia ≥ -1.00D * subject who cannot speak with the operator including those staff of local optometrists or ophthalmologists
Where this trial is running
Beijing, Beijing Municipality and 2 other locations
- Airdoc MPC Opthalmology Clinics — Beijing, Beijing Municipality, China (NOT_YET_RECRUITING)
- Jenny QIU — Beijing, Beijing Municipality, China (RECRUITING)
- Qiu Jenny — Beijing, Haidian District, China (RECRUITING)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Myopia, Myopia, Moderate, Astigmatism, software, refraction, subjective refraction, mobilerone, myopia